Carcinoma in situ of the scrotum is a localized, non-invasive malignancy characterized by abnormal cell growth confined to the scrotal tissue. It is clinically significant as it may progress to invasive cancer if left untreated. Accurate coding with ICD-10 Code D07.61 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring appropriate management and resource allocation.
ICD-10 Code D07.61 specifically denotes carcinoma in situ of the scrotum, indicating the presence of abnormal cells that have not invaded surrounding tissues. This code is utilized in clinical documentation and billing when diagnosing patients with this condition, facilitating accurate treatment planning and reimbursement processes.
Carcinoma in situ of the scrotum arises from the epithelial cells and is often associated with risk factors such as chronic irritation or exposure to carcinogens. It requires prompt medical attention to prevent progression to invasive cancer. Early detection and intervention are crucial for favorable outcomes.
ICD-10 Code D07.61 is integral in SOAP notes for documenting the patient's symptoms, assessment findings, and treatment plans. It aids in both acute and chronic care settings, ensuring comprehensive patient management and facilitating accurate billing.
In SOAP notes, ICD-10 Code D07.61 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of carcinoma in situ of the scrotum. This ensures continuity of care, supports billing processes, and meets EHR documentation standards.
Prompt treatment of carcinoma in situ of the scrotum is essential to prevent progression to invasive cancer. Surgical excision is the primary treatment modality.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D07.61 is crucial for accurate billing in hospital, ER, or outpatient settings, ensuring proper reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 11600 | Excision, malignant skin lesion, face, ears, scalp, neck; excised diameter excised 0.5 cm or less. |
| 11100 | Biopsy of skin, subcutaneous tissue, or mucous membrane. |
| 99213 | Established patient office visit, Level 3. |
Common Questions About Using ICD-10 Code D07.61 for Carcinoma in situ of scrotum
What are the risk factors for carcinoma in situ of the scrotum?
Risk factors include chronic irritation, exposure to carcinogenic substances, and a history of skin conditions. Regular skin examinations are recommended for individuals at higher risk.
How is carcinoma in situ of the scrotum diagnosed?
Diagnosis typically involves a physical examination followed by a biopsy of the scrotal lesion to confirm the presence of abnormal cells.
What treatment options are available for carcinoma in situ of the scrotum?
The primary treatment is surgical excision of the affected tissue. Follow-up care is essential to monitor for recurrence.
Is carcinoma in situ of the scrotum contagious?
No, carcinoma in situ is not contagious. It is a localized cancer that does not spread from person to person.
Clinical Notes
SOAP notes
DAP notes
AI medical notes